Ohio State quarterback Quinn Ewers has his first endorsement deal. The newly reclassified No. 1 overall recruit within the 2021 cycle launched a 45-second commercial on his Twitter web page for Holy Kombucha, a Texas-based drinks firm. Holy Kombucha, which can also be partnering with Hope Squad for psychological well being and suicide prevention packages, was all in favour of signing Ewers in response to a report from Pete Thamel of Yahoo Sports in late July.
Clearly, the curiosity was reciprocal. Ewers can now earn money off his identify, picture and likeness — a driving power behind his reclassification to the Class of 2021 and signing with Ohio State. The nation’s No. 1 total prospect from Texas highschool powerhouse Southlake Carroll introduced on Aug. 2 that he can be graduating a yr early and enrolling with the Buckeyes throughout preseason camp.
Reclassifying is not unprecedented, however the brand new pursuit of NIL offers is, and it provides an additional layer to Ewers’ resolution. He enters camp with a heated battle to switch Justin Fields already underway amongst C.J. Stroud, Kyle McCord and Jack Miller — the primary two of which have been additionally one-time five-star recruits. Ewers’ incomes energy merely as a blue-chip recruit is excessive. How that develops throughout his time at Ohio State can be a narrative to look at.
You’ll be able to watch Ewers’ video beneath:
Ewers arrives at Ohio State with a bunch of fanfare and recruiting rankings which are comparable with Trevor Lawrence. His numbers have been absurd. He threw for six,445 yards, 73 touchdowns and solely eight interceptions throughout his remaining two seasons of highschool soccer regardless of lacking six video games in the course of the 2020 season. He additionally added 701 dashing yards and eight touchdowns on the bottom during the last two seasons.
https://www.cbssports.com/college-football/information/new-ohio-state-qb-quinn-ewers-debuts-his-first-nil-endorsement-deal/ | New Ohio State QB Quinn Ewers debuts his first NIL endorsement deal